Research highlights how GLP-1 receptor agonists may improve brain health by targeting the neurovascular unit, linking ...

Ozempic is the word on everyone's lips, and research reveals that the market for weight management supplements is worth over five billion USD, with analysts predicting a 14% uptick in the next ten ...

GLP-1 drugs are being recommended on social media, raising questions about who can see the content and what the effects might ...

As more Americans are prescribed glucagon-like peptide-1 receptor agonist drugs, concerns are rising about how to best manage associated adverse ...

With a new patent settlement, generic partners Mylan and Natco have cleared one hurdle to a potential U.S. launch of their ...

As signs emerge that demand for GLP-1 drugs is stronger than expected, many are fearing the worst for packaged-food companies, but Bernstein believes that some companies are likely to fare better than ...

In phase 2, VK2735 reduced patients' weight by about 15% after 13 weeks of treatment and maintained a clean safety profile.

As you are likely aware, many people are using a class of drugs called GLP-1 receptor agonists for weight loss. One of the ...

Pfizer (NYSE: PFE) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...

Mice given semaglutide, the key ingredient in drugs like Ozempic and Wegovy, lost weight, but they also voluntarily ran less on a wheel.

Whilst it can work as an affective weight-loss drug for those who are obese, it should never be used for a short-term ...

The drug, initially intended for use by diabetics, has soared in popularity as a result of the weight-loss effects.